GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $344,000 | +130.9% | 5,064 | +7.9% | 0.02% | +150.0% |
| Q2 2022 | $149,000 | -8.6% | 4,693 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $163,000 | +19.0% | 4,693 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $137,000 | +14.2% | 4,693 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $120,000 | -26.8% | 4,693 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $164,000 | -38.1% | 4,693 | -9.4% | 0.01% | -60.0% |
| Q1 2020 | $265,000 | -34.1% | 5,178 | +2.3% | 0.02% | -16.7% |
| Q4 2019 | $402,000 | +71.8% | 5,062 | +5.1% | 0.02% | +63.6% |
| Q3 2019 | $234,000 | -3.7% | 4,817 | +4.1% | 0.01% | 0.0% |
| Q2 2019 | $243,000 | +3.8% | 4,626 | +4.8% | 0.01% | 0.0% |
| Q1 2019 | $234,000 | +41.0% | 4,415 | +9.0% | 0.01% | +22.2% |
| Q4 2018 | $166,000 | +7.8% | 4,051 | 0.0% | 0.01% | +28.6% |
| Q3 2018 | $154,000 | -15.8% | 4,051 | 0.0% | 0.01% | -22.2% |
| Q2 2018 | $183,000 | +16.6% | 4,051 | +25.0% | 0.01% | +12.5% |
| Q1 2018 | $157,000 | +22.7% | 3,241 | 0.0% | 0.01% | +33.3% |
| Q4 2017 | $128,000 | +30.6% | 3,241 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $98,000 | +10.1% | 3,241 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $89,000 | +41.3% | 3,241 | +90.3% | 0.00% | +33.3% |
| Q1 2017 | $63,000 | – | 1,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |